We have recently reported that nitrite reductase, a bifunctional enzyme located in the periplasmic space of Pseudomonas aeruginosa, could induce interleukin-8 (IL-8) generation in a variety of respiratory cells, including bronchial epithelial cells (K. Oishi et al. Infect. Immun. 65:2648-2655, 1997). In this report, we examined the mode of nitrite reductase (PNR) release from a serum-sensitive strain of live P. aeruginosa cells during in vitro treatment with four different antimicrobial agents or human complement. Bacterial killing of P. aeruginosa by antimicrobial agents induced PNR release and mediated IL-8 production in human bronchial epithelial (BET-1A) cells. Among these agents, imipenem demonstrated rapid killing of P. aeruginosa as well as rapid release of PNR and resulted in the highest IL-8 production. Complement-mediated killing of P. aeruginosa was also associated with PNR release and enhanced IL-8 production. The immunoprecipitates of the aliquots of bacterial culture containing imipenem or complement with anti-PNR immunoglobulin G (IgG) induced a twofold-higher IL-8 production than did the immunoprecipitates of the aliquots of bacterial culture with a control IgG. These pieces of evidence confirmed that PNR released in the aliquots of bacterial culture was responsible for IL-8 production in the BET-1A cells. Furthermore, the culture supernatants of the BET-1A cells stimulated with aliquots of bacterial culture containing antimicrobial agents or complement similarly mediated neutrophil migration in vitro. These data support the possibility that a potent inducer of IL-8, PNR, could be released from P. aeruginosa after exposure to antimicrobial agents or complement and contributes to neutrophil migration in the airways during bronchopulmonary infections with P. aeruginosa.
Cell culture. BET-1A, which is a human bronchial epithelial cell line transformed by simian virus 40, was cultured in serum-free LHC-9 media (Biofluids, Rockville, Md.) with 25 g of amphotericin B per ml, 25 U of penicillin per ml, and 25 g of streptomycin per ml in a 24-well plate coated with fibronectin and collagen (24) . The BET-1A cell line was employed for determination of nonlipopolysaccharide (LPS)-mediated IL-8 production because of its lack of responsiveness to LPS stimulation (27) . After confluent cultures had been washed with HEPES-buffered saline, cells were incubated with purified PNR or the aliquots of bacterial culture with antimicrobial agents or absorbed normal human serum (AbsNHS), diluted with LHC-9 medium. Lactate dehydrogenase release was measured to assess cell viability by using an in vitro toxicology assay kit (Sigma Chemical Co. St. Louis, Mo.) and never exceeded 5% release under these conditions. The uniformity of the monolayer was also determined by quantifying the number of cells per well. Cell-free supernatants of culture media were harvested after incubation for the indicated times. All supernatants of culture media were stored at Ϫ80°C for less than a week until tested with the enzymelinked immunosorbent assay (ELISA) for IL-8 and the NCF assay. Each value represents the mean Ϯ standard deviation of three determinations.
IL-8 assay. IL-8 levels were determined by an ELISA with a monoclonal antibody WS 4 as the capturing antibody and a polyclonal rabbit anti-IL-8 antibody as a secondary antibody, both of which were raised against human recombinant IL-8 as previously described (16) . The detection limit of this assay was 31.1 pg of IL-8 per ml.
Bacterial killing by antimicrobial agents. The MICs of imipenem (Banyu Pharmaceutical, Co., Ltd., Japan), ceftazidime (Glaxo, Tokyo, Japan), levofloxacin (Daiichi Pharmaceutical Co., Ltd., Japan), and gentamicin (Wako Pure Chemical Co., Ltd., Osaka, Japan) were determined by the standard method as previously described (6) . The MICs of imipenem, ceftazidime, levofloxacin, and gentamicin were all 1.56 g/ml. Levels of imipenem, ceftazidime, or gentamicin 10ϫ the MIC or a level of levofloxacin 5ϫ the MIC and P. aeruginosa 5276 at a concentration of 5 ϫ 10 8 CFU/ml were employed to demonstrate bacterial killing and PNR release in vitro. Ten milliliters of bacterial suspension in chemically defined M9 medium was incubated in a sterile glass tube at 37°C for 1, 3, 5, and 12 h with continuous shaking (2) . Aliquots were removed from triplicate samples for quantitative culture. The aliquots of bacterial culture containing antimicrobial agents were used for PNR detection by immunoblot analysis and immunoprecipitation after filter sterilization, in addition to stimulation of BET-1A cells after 1:10 dilution in LHC-9 medium.
Complement-mediated killing. Veronal-buffered saline containing 0.1% (wt/ vol) gelatin, 0.15 mM CaCl 2 , and 1.0 mM MgCl 2 (GVB ϩϩ ) was used. AbsNHS was prepared as previously described (29) . Briefly, separated sera were absorbed with P. aeruginosa 5276 by incubation in 1-ml aliquots with 5 ϫ 10 8 CFU of bacteria per ml for 1 h at 0°C, removing bacteria by centrifugation at 2,000 ϫ g for 10 min at 4°C, repeating the absorption, and filter sterilization of AbsNHS, the samples of which were stored in aliquots at Ϫ80°C before use. Complement activity was abolished by heating the serum at 56°C for 30 min. Fifty percent AbsNHS and P. aeruginosa 5276 at a concentration of 5 ϫ 10 8 CFU/ml were employed to demonstrate bacterial killing and PNR release in vitro. Complement-mediated killing was determined by incubating 5 ϫ 10 8 CFU of bacteria per ml with 50% AbsNHS or 50% heat-inactivated AbsNHS suspended in 1.0 ml of GVB ϩϩ with continuous shaking at 37°C for 1 h. Aliquots were removed from triplicate samples for quantitative culture. After separation of the supernatants of bacterial culture by centrifugation at 2,000 ϫ g for 10 min at 4°C, the supernatants were filter sterilized and used for IL-8-inducing activity in BET-1A cell cultures and for detection of PNR by immunoblot analysis and immunoprecipitation. These supernatants, diluted 1:50 in LHC-9 medium, were tested with the BET-1A cells.
Immunoblotting. The purified PNR or aliquots of bacterial culture containing antimicrobial agents or complement were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (10% polyacrylamide), transferred to a polyvinylidene difluoride membrane, analyzed by immunoblotting with a polyclonal rabbit immunoglobulin G (IgG) against recombinant PNR at 1 g/ml (27) and horseradish peroxidase-conjugated streptavidin (Amersham, Little Chalfont, United Kingdom), and subjected to detection by enhanced chemiluminescence (Amersham).
Immunoprecipitation. Immunoprecipitation was done as previously described (27) . In brief, a 400-l volume of the 10-fold-concentrated aliquots of bacterial culture with imipenem at 5 h postincubation or 2-fold-concentrated aliquots of bacterial culture with AbsNHS at 1 h postincubation was incubated with a 100-l volume of anti-PNR rabbit IgG (6 mg/ml) or the same volume of control rabbit IgG (6 mg/ml; Cappel, West Chester, Pa.) at 4°C overnight. A 100-l volume of protein G-Sepharose (Pharmacia Biotech, Uppsala, Sweden) in 20 mM sodium phosphate (pH 7.0) was added to the reaction mixtures, which were then incubated at 35°C for 60 min. Immunoprecipitates were washed three times with 0.5 ml of phosphate-buffered saline and were incubated with 0.2 ml of glycine-HCl (pH 2.7) for 5 min. The reaction mixtures were centrifuged at 13,000 ϫ g for 5 min, and the supernatants containing immunoprecipitates released from protein G-Sepharose were separated and dialyzed against phosphate-buffered saline at 4°C. A total of 0.2 ml of dialyzed samples was analyzed with the BET-1A cell culture and by immunoblotting.
NCF activity. NCF activities in culture supernatants of the BET-1A cells were determined by using an assembly consisting of a 96-well chamber, polycarbonate filter membrane, and a 96-well microtiter plate (Neuro Probe, Inc., Gaithersburg, Md.) according to the manufacturer's instructions (14) . Neutrophils were purified from the peripheral blood of normal volunteers by dextran sedimentation and Ficoll-Hypaque density gradient centrifugation and suspended at a concentration of 2 ϫ 10 7 cells per ml in RPMI-1640 containing 1 mM L-glutamine and 25 mM HEPES. Both the purity and the cell viability of neutrophils were determined to be Ͼ99%. Thirty microliters of the culture supernatant or 10 ng of recombinant human IL-8 (Genzyme, Cambridge, Mass.) per ml was placed in triplicate in the bottom wells of the chamber separated by a polycarbonate membrane filter with pores 3 m in diameter. Twenty-five microliters of neutrophil suspension (5 ϫ 10 5 cells/well) was added to the membrane filter. The chamber was incubated for 1 h at 37°C in humidified 95% air-5% CO 2 . After a 1-h incubation, the neutrophils that had migrated through the membrane filter were sedimented by centrifugation at 250 ϫ g for 15 min at room temperature and lysed by adding 6 l of 0.2% (vol/vol) of Triton X-100 (Feinbiochemical GmbH & Co., Heidelberg, Germany). Liberated peroxidase activity was measured by adding 24 l of 0.34 mM O-dianisidine (3,3Ј-dimethoxybenzine, Sigma Chemical Co.) in 0.05 M phosphate-citrate buffer (pH 5.0), containing 0.02% (vol/vol) of a 30% H 2 O 2 solution. After incubation for 15 min at room temperature, the optical density at 405 nm was measured with a microplate reader (Labsystems Multiscan, Needham Heights, Mass.). NCF activities were expressed as migrated neutrophil numbers per well as previously described (14) . In neutralizing antibody studies, 45 l of culture supernatants of BET-1A cells was incubated with 5 l of anti-IL-8 polyclonal rabbit IgG (1 mg/ml; Endogen, Inc., Boston, Mass.) or control rabbit IgG (1 mg/ml; Cappel) for 1 h at 37°C and then employed in the NCF assay. Anti-IL-8 polyclonal rabbit IgG at 100 g/ml completely neutralized neutrophil chemotaxis of recombinant IL-8, at least at the level of 10 ng/ml. The levels of IL-8 in the culture supernatants of the BET-1A cells were all less than 10 ng/ml. The percent reduction of NCF activity was determined as [1 Ϫ (NCF with anti-IL-8 IgG Ϫ baseline NCF with anti-IL-8 IgG/NCF with control IgG Ϫ baseline NCF with control IgG)] ϫ 100.
Statistical analysis. Differences in the bacterial numbers and levels of IL-8 production by the BET-1A cells among five groups were determined with a Kruskall-Wallis test and Bonferroni method for multiple comparisons. The differences in the NCF activities were analyzed by the paired Student's t test. Data were considered statistically significant if P values were less than 0.05.
RESULTS

Killing of P. aeruginosa and PNR release by antimicrobial agents.
Among different antimicrobial agents, levofloxacin showed the most rapid and the highest level of killing at 1 h postincubation ( Fig. 1A) . Each antimicrobial agent significantly suppressed the bacterial numbers, compared with M9 medium alone at 1, 3, 5, and 12 h (P Ͻ 0.005). The rankings of bacterial killing by each antimicrobial agent were as follows: levofloxacin Ͼ imipenem Ͼ ceftazidime and gentamicin. There was no statistical difference between the numbers of P. aeruginosa cells treated with ceftazidime and gentamicin at each indicated time. The immunoblot analysis showed a faint band at 1 h and a broad band with a molecular mass of 60 kDa at 5 and 12 h after the treatment with imipenem ( Fig. 2 ). The levels of PNR released by addition of imipenem appeared to be more than 1 g/ml based on the detection limit of the immunoblot assay. Ceftazidime demonstrated PNR release at 5 and 12 h posttreatment, and levofloxacin and gentamicin showed PNR release only at 12 h posttreatment.
Induction of IL-8 production in BET-1A cells. The aliquots of bacterial culture containing each antimicrobial agent were added to the culture of BET-1A cells, and imipenem was found to induce both the most rapid and the highest production of IL-8 ( Fig. 1B) , while imipenem, ceftazidime, gentamicin, or levofloxacin alone did not stimulate IL-8 production in the same cells. The levels of IL-8 production induced by imipenem were significantly higher than those induced by the other antimicrobial agents at each indicated time (P Ͻ 0.001). The levels of IL-8 production induced by ceftazidime were also significantly higher than those induced by gentamicin, levofloxacin, and the control at 5 and 12 h posttreatment (P Ͻ 0.05). Interestingly, the lowest and slowest production of IL-8 was induced by levofloxacin, which showed the highest bacterial killing, and gentamicin, which showed a lower level of bacterial killing. The potency of the induction of IL-8 by each antimicrobial agent was demonstrated in the following order: imipenem Ͼ ceftazidime Ͼ levofloxacin and gentamicin. The induction of IL-8 production in the BET-1A cells by each antimicrobial agent was correlated to the release of PNR from P. aeruginosa. These data indicate that bacterial killing by imipenem rapidly induced PNR release and IL-8 production in the BET-1A cell culture, while bacterial killing by ceftazidime, levofloxacin, or gentamicin resulted in slower PNR release and consequently delayed IL-8 production.
Immunoprecipitation of aliquots of bacterial culture containing imipenem. To confirm whether PNR release is responsible for IL-8 production-associated bacterial killing by imipenem in the BET-1A cells, immunoprecipitates of the aliquots of bacterial culture containing imipenem with anti-PNR IgG or control IgG were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and visualized by immunoblotting with anti-PNR IgG. The immunoblot analysis with anti-PNR IgG exhibited a broad band with a molecular mass of 60 kDa in the immunoprecipitates of the aliquots of bacterial culture containing imipenem with anti-PNR IgG, but exhibited no band with the same molecular mass in the aliquots of bacterial culture containing imipenem with control IgG (Fig. 3A) . Furthermore, the level of induction of IL-8 production (1.20 Ϯ 0.11 ng/ml) by the BET-1A cells in response to the dialyzed immunoprecipitates of the aliquots of bacterial culture containing imipenem with anti-PNR IgG was significantly higher than that in response to the immunoprecipitates of the aliquots of bacterial culture containing imipenem with control IgG (0.58 Ϯ 0.08 ng/ml; P Ͻ 0.05) ( Fig. 3B ). These data confirmed that PNR released from P. aeruginosa by imipenem was responsible for induction of IL-8 production in the BET-1A cells.
Complement-mediated bacteriolysis of P. aeruginosa and PNR release and induction of IL-8 production in BET-1A cells. Treatment of P. aeruginosa 5276 at 5 ϫ 10 8 CFU/ml with AbsNHS Immunoprecipitation of aliquots of bacterial culture containing complement. The immunoblot analysis with anti-PNR IgG exhibited a broad band with a molecular mass of 60 kDa in the immunoprecipitates of the aliquots of bacterial culture containing AbsNHS with anti-PNR IgG but exhibited no band with the same molecular mass in the immunoprecipitates of the aliquots of bacterial culture containing AbsNHS with a control IgG (Fig. 5A ). Furthermore, induction of IL-8 production (1.02 Ϯ 0.13 ng/ml) by the BET-1A cells in response to the dialyzed immunoprecipitates of the aliquots of bacterial culture containing AbsNHS with a polyclonal IgG against PNR was significantly higher (0.50 Ϯ 0.09 ng/ml; P Ͻ 0.05) than that in response to the immunoprecipitates of the aliquots of bac-terial culture containing AbsNHS with a control IgG (Fig. 5B) . These data confirmed that PNR release associated with complement-mediated bacteriolysis was responsible for induction of IL-8 production in the BET-1A cells.
NCF activity in the culture supernatants of BET-1A cells. We next examined NCF activity in the culture supernatants of the BET-1A cells stimulated with the aliquots of bacterial culture containing each antimicrobial agent and AbsNHS. The NCF activity mediated by the culture supernatants of the BET-1A cells stimulated with the aliquots of bacterial culture containing imipenem, ceftazidime, levofloxacin, or gentamicin is shown in Fig. 6A . The aliquots of bacterial culture containing imipenem harvested at various time points demonstrated the highest NCF activity among these antimicrobial agents. The aliquots of bacterial culture containing levofloxacin or gentamicin only at 12 h postincubation showed increased the NCF activities. We observed a ranking of potency in induction of NCF activity by the aliquots of bacterial culture containing each antimicrobial agent similar to that of the induction of IL-8 production in the BET-1A cells shown in Fig. 1B , but the levels of bacterial killing were not similar. We also performed neutralizing antibody experiments to determine how much IL-8 contributed to NCF activities of the aliquots of bacterial culture containing imipenem, by using antihuman IL-8 or control IgG. As shown in Fig. 6B , preincubation with anti-IL-8 IgG resulted in a significant reduction in the NCF activities of the aliquots of bacterial culture harvested at 1 (8,326 Ϯ 71 versus 7,219 Ϯ 71; P Ͻ 0.05), 3 (12,018 Ϯ 309 versus 8,203 Ϯ 142; P Ͻ 0.05), 5 (13,660 Ϯ 539 versus 10,418 Ϯ 554; P Ͻ 0.05) and 12 (16, 776 Ϯ 677 versus 12,387 Ϯ 606; P Ͻ 0.05) h postincubation with imipenem. The mean percent reductions of NCF activities were 33% at 1 h, 56% at 3 h, 38% at 5 h, and 38% at 12 h, respectively.
The NCF activity of the aliquots of bacterial culture containing AbsNHS was significantly higher than that of heat-inactivated AbsNHS (P Ͻ 0.01) ( Fig. 7) . A similar preincubation with anti-IL-8 IgG demonstrated a significant reduction of NCF activities of aliquots of bacterial culture containing heatinactivated AbsNHS (31,320 Ϯ 2,775 versus 15,627 Ϯ 647; P Ͻ 0.05) and AbsNHS (41,578 Ϯ 2,684 versus 22,885 ϩ 1,205; P Ͻ 0.05). The mean percent reductions of NCF activities were 58% in heat-inactivated AbsNHS and 50% in AbsNHS. These data suggest there is significant participation of IL-8 in the NCF activity in the culture supernatants of BET-1A cells generated in response to aliquots of bacterial culture containing imipenem or serum factors.
DISCUSSION
In this paper, PNR was found to be released from a serumsensitive strain of P. aeruginosa, 5276, after exposure to different antimicrobial agents. Among these agents, treatment with imipenem, a carbapenem, at 10ϫ the MIC caused the most rapid release of PNR during the killing of P. aeruginosa cells and in turn induced the highest production of IL-8 in BET-1A cell cultures. Imipenem at 5ϫ the MIC also induced a rapid killing of P. aeruginosa 5276 and a high level of production of IL-8 in BET-1A cell cultures (data not shown). Treatment with ceftazidime, a cephalosporin, at 10ϫ the MIC caused a slower release of PNR and a much lower level of IL-8 production. The concentrations of these ␤-lactam antibiotics used in this study have been reported to be clinically achievable in plasma and lung tissues (3, 20) . We also confirmed a similar feature of PNR release and induction of IL-8 production in the BET-1A cells following bacterial killing of P. aeruginosa Fisher immunotype 1, a serum-resistant strain, by 4ϫ the MIC of imipenem (data not shown).
These data for PNR release from P. aeruginosa induced by ␤-lactam antibiotics differ from published data on endotoxin release by them. Ceftazidime, binding to PBP 3, released a larger amount of endotoxin from P. aeruginosa than imipenem, binding to PBP 2 (13) . The endotoxin thus released has a variety of biological functions in vitro and in vivo. Nakano and Kirikae demonstrated that nanogram levels of ceftazidimereleased endotoxin induced tumor necrosis factor, IL-6, and nitric oxide production in cultured peritoneal macrophages from LPS-responsive C3H/HeN and LPS-hyporesponsive C3H/HeJ mice, and lethal toxicity in D-(ϩ)-galactosamine-sensitized mice (15, 25) . Another recent paper demonstrated that PBP 2-specific imipenem-induced endotoxin release stimulated endothelial cells or whole blood cells to produce less IL-6 than did PBP 3-specific ceftriaxone and meropenem (1) . Treatment of enterohemorrhagic Escherichia coli strains with imipenem similarly induced much lower levels of release of Shiga-like toxin, as well as endotoxin, than treatment with ceftazidime (41). Prins et al. reported that serum and urine cytokine levels increased by 10-to ϳ40% after 4 h of ceftazidime treatment compared with no increase in imipenem-treated patients with gram-negative urosepsis (34) . The lower levels of endotoxin release resulting from treatment with PBP 2 binding antibiotics may be explained by their rapid bactericidal actions, suppressing any increase in total cell mass. In addition, ciprofloxacin and gentamicin at levels of 16ϫ the MIC have been reported to be potent inducers of endotoxin release (42) .
On the other hand, the level of PNR release and IL-8 induction in the BET-1A cells after treatment with ␤-lactam antibiotics appears to be dependent on bactericidal effects, rather than total cell mass. Outer membrane damage associated with ␤-lactam antibiotic-induced bacterial killing may explain PNR release from the periplasmic space of P. aeruginosa, resulting in IL-8 induction in the BET-1A cells. In contrast, levofloxacin or gentamicin at levels higher than the MIC induced the slowest PNR release and the lowest IL-8 production in BET-1A cells, although the levels of these agents used in this study were higher than the clinically achievable levels in the airways (18, 26) . Slower bacterial killing by gentamicin at a level over the MIC induced the slowest PNR release, because a mild bactericidal action of aminoglycoside could be caused by outer membrane damage due to incorporation of misread protein (8) . The most rapid and the highest bactericidal action by levofloxacin, a fluoroquinolone, may involve minimal damage of the outer membrane, because the mode of bacterial killing by levofloxacin did not correlate with its mode of PNR release. In fact, our preliminary studies with electron microscopy confirmed minimal damage on the surfaces of P. aeruginosa cells after treatment with levofloxacin or gentamicin (data not shown). Levofloxacin, therefore, appeared to induce a rapid bacterial killing of P. aeruginosa without any serious damage to the cell surfaces. Although bacterial killing by quinolone agents appeared to require drug interaction with DNA gyrase, the molecular events in this phenomenon remain unknown. In contrast, serious damage to the outer membrane of imipenemtreated cells and a filamentous alteration of ceftazidime-treated cells were also observed by electron microscopy (data not shown). These pieces of evidence from our preliminary studies support minimal release of PNR by levofloxacin or gentamicin and maximum release of PNR by imipenem, as shown in Fig.  2 . Consequently, the grade of PNR release by these antimicrobial agents well correlated with the levels of IL-8 production in the BET-1A cells.
The essential requirement of complement for clearance of microorganisms has been described previously (7) . Complement activation can lead to microbial lysis, but it also plays an important role in phagocytosis and neutrophil recruitment. Up to 50-to 80% of strains of mucoid P. aeruginosa isolated from patients with cystic fibrosis or bronchiectasis and chronic bronchitis were shown to be serum sensitive (31, 39) . Insertion of C5b-9 membrane attack complexes on the outer membrane induced killing of serum-sensitive strains of P. aeruginosa (37) . We also reported that serum-sensitive strains were less virulent than serum-resistant strains in a murine model of pneumonia due to P. aeruginosa (39) . In the present study, complementmediated cell lysis of P. aeruginosa 5276 also released PNR and resulted in induction of IL-8 production in the BET-1A cells. These data may imply that increased levels of complement factors in the airways of patients with bronchopulmonary infections may cause complement-mediated cell lysis of serumsensitive organisms, thereby inducing PNR release and IL-8 production (11) .
Our present study confirmed that imipenem-or complement-stimulated release of PNR was responsible for induction of IL-8 production in the BET-1A cells. PNR released from live P. aeruginosa may also induce a high level of IL-8 by human alveolar macrophages and relatively low levels of IL-8 by neutrophils and pulmonary fibroblasts (27) . However, treatment of P. aeruginosa with an antimicrobial agent or complement may also release nonpeptide IL-8-inducing factors with low molecular masses in bronchial epithelial cells (19, 27) .
The intensity of NCF activity in the culture supernatants of the BET-1A cells induced by the aliquots of bacterial culture containing antimicrobial agents or complement factors was closely correlated with PNR release and induction of IL-8 production in the same cells. In addition, IL-8 was proved to be a major chemoattractant for neutrophils in the culture supernatants of the BET-1A cells, as shown by neutralizing antibody experiments with antihuman IL-8 IgG. A part of NCF activities in culture supernatants of the BET-1A cells may be due to other neutrophil chemotactic factors, such as epithelial cell-derived neutrophil-activating peptide (ENA-78) (17), leukotriene B 4 (21), or platelet-activating factor (36) , which are derived from pulmonary epithelial cells, or other chemotactic peptides from P. aeruginosa itself (12) . However, it has not yet been determined whether PNR induces neutrophil chemoattractants other than IL-8 from bronchial epithelial cells.
These several lines of evidence suggest that PNR released from P. aeruginosa by antimicrobial agents or complement may induce IL-8 production and neutrophil migration in the airways of patients with bronchopulmonary infections. We have previously reported that the levels of IL-8 and the number of neutrophils in expectorated sputum from patients with bacterial bronchopulmonary infections have decreased after treatment with the appropriate antimicrobial agents (33) . Therefore, antibiotic-induced PNR release and neutrophil migration through induction of IL-8 production in the airways may begin after initiation of therapy and gradually decrease during successful antimicrobial chemotherapy. In summary, PNR could be released from live P. aeruginosa cells after exposure to antimicrobial agents or serum complement factors, thereby inducing IL-8 production by bronchial epithelial cells and consequently neutrophil migration in vitro. Our present data may render new insight into a mechanism of neutrophil-mediated inflammations in bronchopulmonary infections with P. aeruginosa and support the idea that PNR-induced IL-8 production and neutrophil migration in the airways contribute to acute or chronic lung injuries associated with bronchopulmonary infections with P. aeruginosa.
